Mr. Michael S. Deland
CEO and Founder
Siddha Flower Essences, LLC., dba Siddha Remedies
2350 Eastman Ave, Suite 107
Oxnard , CA 93030
United StatesFEI 3014145088Issued Nov 4, 2025Center for Drug Evaluation and Research (CDER)
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3014145088.
Violations6
Issue DateNov 4, 2025
Product TypeDrugs
StatusOpen
Letter Details
Firm
Siddha Flower Essences, LLC., dba Siddha Remedies
Location
Mr. Michael S. Deland
CEO and Founder
Siddha Flower Essences, LLC., dba Siddha Remedies
2350 Eastman Ave, Suite 107
Oxnard , CA 93030
United States
FEI Number
3014145088
Country
United States
Issue Date
November 04, 2025
Issuing Office
Center for Drug Evaluation and Research (CDER)
Product Type
Drugs
Status
Open
Summary
Siddha Flower Essences, LLC. was cited for significant Current Good Manufacturing Practice (CGMP) violations in its manufacturing of over-the-counter homeopathic drugs, rendering the products adulterated under federal law. The company failed to maintain proper methods, facilities, and controls for manufacturing, processing, packing, and holding finished pharmaceuticals, and failed to update its human OTC homeopathic drug listings in the FDA's Drug Registration and Listing System as required by regulation. These compliance failures resulted in the company's drug products being misbranded and improperly listed for interstate commerce, violating multiple provisions of the Federal Food, Drug, and Cosmetic Act.
Siddha Flower Essences, LLC., dba Siddha Remedies FDA Warning Letter, November 4, 2025
Talk to a Specialist